It could significantly inhibit breast cancer growth and glycolytic activity in both the transgenic MMTV-PyVT+/− breast cancer spontaneous model and the zebrafish breast cancer xenotransplantation model in vivo by upregulating Cav-1 expression35. Here, CAV1 is linked to breast carcinoma.